What You Should Know: - Biotricity Inc., a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac - a personal, cardiac health application for individuals diagnosed with or at risk for cardiovascular disease. Designed to be used with Samsung's Galaxy Watch4 series, the Biocare Cardiac application continuously collects users' daily activities and provides critical information on
Read More
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know: - Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences. - Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure
What You Should Know: - Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). - The Breakthrough Devices Program was created to provide patients and providers with timely access to medical devices (in this case, software as a medical device, or SaMD) by speeding up their
Read More
Cardiac Success Secures $5.2M for Transcatheter Ventricular Repair Device for Heart Failure Patients
What You Should Know: - Cardiac Success Ltd., an Israel-based medical device company developing a transcatheter ventricular repair device for heart failure patients, announced it has raised $5.2M in Series A funding round led by 415 CAPITAL. The round was joined by an unnamed global strategic leader in structural heart interventions and a group of Israeli angel investors. - Today, there are millions of patients who, despite guidance-directed medical therapy, continue to suffer
Read More
Cleerly Launches with $43M for Digital Care Pathway Solution for Heart Attack Prevention
What You Should Know: - Cleerly, a New York City-based company launched today with $43M in Series B funding and unveiled its first-of-its-kind digital care pathway solution for heart attack prevention. The Series B funding, which was led by Vensana Capital with participation from LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures, and existing investors, brings Cleerly’s total funding to $54M. - Using more than
Read More
Eko’s AI Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs
What You Should Know: - Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial intelligence (AI) algorithm for detecting heart murmurs is accurate and reliable, with comparable performance to that of an expert cardiologist. - The findings suggest utility of the FDA-cleared Eko AI algorithm as a front line clinical tool to aid clinicians in screening for cardiac murmurs
Read More
Mass General, AstraZeneca Pilot Digital Health Program for Asthma, Heart Failure
What You Should Know: - Massachusetts General Hospital (MGH) today announced with AstraZeneca to pilot a new digital health platform focused on heart failure and asthma studies to help improve outcomes for patients with chronic diseases. - This collaboration is being led by the MGH Center for Innovation in Digital Healthcare (CIDH) and will utilize AstraZeneca’s new AMAZE disease management platform in studies for heart failure and asthma management. These first two studies will pilot
Read More
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
How NLP Can Uncover Social Determinants of Heart Disease
Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and
Read More
Spectrum Health Taps TytoCare to Expand Telehealth Offerings
What You Should Know: - Spectrum Health, a not-for-profit, integrated health system based in West Michigan has announced a partnership with TytoCare to expand their telehealth offerings. - The integration of TytoCare into Spectrum Health’s virtual care offering will enhance the health system’s ability to diagnose and treat patients remotely with in-depth, physical examinations during video visits. In an initial pilot with Spectrum Health employees
Read More
